Cite
HARVARD Citation
Dulai, P. et al. (n.d.). P631 Development and validation of a clinical scoring tool for predicting treatment outcomes with vedolizumab in patients with ulcerative colitis. Journal of Crohn's and colitis. p. S433. [Online].